XML 115 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Business Segments
 6 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Business Segments Business Segments
Segment information has been prepared in accordance with the Segment Reporting topic of FASB ASC 280. Our reportable segments consist of (i) North American OTC Healthcare and (ii) International OTC Healthcare. The primary measure used by our chief operating decision maker ("CODM") to evaluate the performance of our operating segments and allocate resources to these segments is contribution margin, which we define as gross profit less advertising and marketing expenses. Information regarding total assets by operating segment is not provided to our CODM. Our CODM is our Chief Executive Officer.

The tables below summarize information about our reportable segments.
 Three Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$230,756 $43,358 $274,114 
Cost of sales102,348 20,187 122,535 
Gross profit128,408 23,171 151,579 
Advertising and marketing32,033 6,668 38,701 
Contribution margin$96,375 $16,503 $112,878 
Other operating expenses 33,208 
Operating income $79,670 
* Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment.
 Six Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$443,334 $80,310 $523,644 
Cost of sales194,526 37,208 231,734 
Gross profit248,808 43,102 291,910 
Advertising and marketing60,987 12,651 73,638 
Contribution margin$187,821 $30,451 $218,272 
Other operating expenses 66,846 
Operating income $151,426 
* Intersegment revenues of $1.2 million were eliminated from the North American OTC Healthcare segment.
 Three Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$239,811 $43,974 $283,785 
Cost of sales107,782 18,621 126,403 
Gross profit 132,029 25,353 157,382 
Advertising and marketing34,889 6,520 41,409 
Contribution margin$97,140 $18,833 $115,973 
Other operating expenses 31,634 
Operating income $84,339 
* Intersegment revenues of $0.9 million were eliminated from the North American OTC Healthcare segment.
 Six Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Total segment revenues*$472,127 $78,800 $550,927 
Cost of sales213,341 34,182 247,523 
Gross profit 258,786 44,618 303,404 
Advertising and marketing68,642 12,132 80,774 
Contribution margin$190,144 $32,486 $222,630 
Other operating expenses 66,245 
Operating income $156,385 
* Intersegment revenues of $1.6 million were eliminated from the North American OTC Healthcare segment.


The tables below summarize information about our segment revenues from similar product groups.
Three Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$27,232 $1,501 $28,733 
Cough & Cold20,472 6,813 27,285 
Women's Health50,588 5,608 56,196 
Gastrointestinal46,413 17,787 64,200 
Eye & Ear Care29,387 4,790 34,177 
Dermatologicals32,792 2,904 35,696 
Oral Care21,039 3,728 24,767 
Other OTC2,833 227 3,060 
Total segment revenues$230,756 $43,358 $274,114 
Six Months Ended September 30, 2025
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$54,490 $3,175 $57,665 
Cough & Cold33,825 12,467 46,292 
Women's Health102,234 10,720 112,954 
Gastrointestinal90,109 31,875 121,984 
Eye & Ear Care57,168 9,317 66,485 
Dermatologicals60,644 5,161 65,805 
Oral Care39,193 7,276 46,469 
Other OTC5,671 319 5,990 
Total segment revenues$443,334 $80,310 $523,644 

Three Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$27,147 $1,075 $28,222 
Cough & Cold23,054 6,221 29,275 
Women's Health54,309 6,038 60,347 
Gastrointestinal41,911 18,150 60,061 
Eye & Ear Care36,140 6,646 42,786 
Dermatologicals33,640 2,215 35,855 
Oral Care20,698 3,385 24,083 
Other OTC2,912 244 3,156 
Total segment revenues$239,811 $43,974 $283,785 
Six Months Ended September 30, 2024
(In thousands)North American OTC
Healthcare		International OTC
Healthcare		Consolidated
Analgesics$54,158 $2,357 $56,515 
Cough & Cold38,015 11,957 49,972 
Women's Health104,804 10,121 114,925 
Gastrointestinal86,198 31,878 118,076 
Eye & Ear Care79,459 11,457 90,916 
Dermatologicals65,243 3,967 69,210 
Oral Care38,372 6,485 44,857 
Other OTC5,878 578 6,456 
Total segment revenues$472,127 $78,800 $550,927